Pediatrics · Glycogen Storage Disease Type IX

Understanding the Subtypes and Genetics of GSD IX

At a Glance

Glycogen Storage Disease Type IX (GSD IX) has several subtypes (IXa, IXb, IXc, IXd) caused by different gene mutations. Knowing a child's specific subtype is critical for predicting long-term health, as symptoms and inheritance patterns vary widely even among children with the same mutation.

While “GSD IX” is the broad name for your child’s condition, it is actually a family of several different subtypes ^[1]. Each subtype is caused by a “typo” in a different gene, and knowing your child’s exact subtype is the most important piece of information for predicting their long-term health and deciding on a monitoring plan ^[2]^[3].

The Subtypes of GSD IX

The phosphorylase kinase (PhK) enzyme is made of several different parts. Depending on which part is “broken,” a child will have a different subtype:

GSD IXa (PHKA2 gene): This is the most common form ^[4]. It primarily affects the liver. Most children with IXa have a very positive outlook, with symptoms that often improve as they grow ^[5]^[6].
GSD IXb (PHKB gene): This form affects both the liver and, occasionally, the muscles ^[7]^[8]. Like IXa, it is generally considered one of the milder forms of GSD ^[2].
GSD IXc (PHKG2 gene): Also known as IXg2, this is often the most severe hepatic (liver) form ^[9]^[10]. Children with this subtype are at a higher risk for liver fibrosis (scarring) and cirrhosis (advanced scarring) and require more frequent liver monitoring ^[2]^[5].
GSD IXd (PHKA1 gene): This is an “ultrarare” version that primarily affects the muscles rather than the liver ^[11]. It may cause muscle weakness, cramps, or fatigue during exercise ^[12]^[13].

How GSD IX is Inherited

The way GSD IX is passed down from parents to children depends on which gene is involved.

Inheritance Type	Subtypes	How it Works
X-Linked	IXa and IXd	The gene is on the X chromosome. This means it primarily affects boys. Mothers are typically “carriers” who may have no symptoms or very mild ones ^[14]^[12].
Autosomal Recessive	IXb and IXc	To have this form, a child must inherit one “broken” gene from each parent. It affects boys and girls equally ^[14]^[5].

Understanding “Phenotypic Variability”

One of the most confusing parts of GSD IX is that even two children with the exact same genetic “typo” can have different symptoms ^[15]. This is called phenotypic variability ^[3].

One child may have a very large liver and feel fine, while another with the same subtype may have a smaller liver but struggle more with fatigue or growth ^[15]^[16].
In some cases, children might even show symptoms like hypotonia (low muscle tone) or slight developmental delays early in life, even if their liver symptoms are mild ^[17].

Because of this variability, your medical team will focus more on how your child is growing and feeling rather than just looking at their genetic code or lab numbers ^[5]^[18]. Your child’s journey is unique to them, and the subtype is simply the starting map for their care.

Common questions in this guide

What is the most common subtype of GSD IX?

GSD IXa is the most common form of the condition. It primarily affects the liver, and symptoms often improve as a child grows older, giving it a generally positive long-term outlook.

How is GSD IX inherited?

Inheritance depends on the specific gene involved. Subtypes IXa and IXd are X-linked and primarily affect boys. Subtypes IXb and IXc are autosomal recessive, meaning a child must inherit a copy of the gene from both parents, and they affect boys and girls equally.

What makes GSD IXc different from other subtypes?

GSD IXc, caused by a mutation in the PHKG2 gene, is typically the most severe liver form of the disease. Children with this subtype have a higher risk of liver scarring (fibrosis) or cirrhosis, which requires closer medical monitoring.

Why do children with the same GSD IX mutation have different symptoms?

This is due to a concept called phenotypic variability. Even when two children share the exact same genetic mutation, they can experience completely different symptoms, ranging from mild liver enlargement to muscle fatigue and developmental delays.

Curated prompts to bring to your next appointment.

1.Which specific gene was identified on my child's report—PHKA2, PHKB, PHKG2, or PHKA1?
2.Since my child has a PHKG2 mutation (GSD IXc), what is our plan for monitoring for liver fibrosis or cirrhosis?
3.Can you explain the 'inheritance pattern' for our family—who else might be a carrier or at risk of having GSD IX?
4.Is there any specific genotype-phenotype information available for my child's exact mutation?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (18)

1
Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients.
Sperb-Ludwig F, Pinheiro FC, Bettio Soares M, et al.
Molecular genetics & genomic medicine 2019; (7(11)):e877 doi:10.1002/mgg3.877.
PMID: 31508908
2
Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX.
Fernandes SA, Cooper GE, Gibson RA, Kishnani PS
Molecular genetics and metabolism 2020; (131(3)):299-305 doi:10.1016/j.ymgme.2020.10.004.
PMID: 33317799
3
Understanding Glycogen Storage Disease Type IX: A Systematic Review with Clinical Focus-Why It Is Not Benign and Requires Vigilance.
Candela E, Montanari G, Zanaroli A, et al.
Genes 2025; (16(5)) doi:10.3390/genes16050584.
PMID: 40428406
4
PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations.
Choi R, Park HD, Kang B, et al.
BMC medical genetics 2016; (17()):33 doi:10.1186/s12881-016-0295-1.
PMID: 27103379
5
Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene.
Waheed N, Saeed A, Ijaz S, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(9)):1117-1123 doi:10.1515/jpem-2019-0603.
PMID: 32697758
6
PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia only.
Benner A, Alhaidan Y, Lines MA, et al.
American journal of medical genetics. Part A 2021; (185(10)):2959-2975 doi:10.1002/ajmg.a.62383.
PMID: 34117828
7
Glycogen Storage Disorder Type IXb: Exploring Clinical Patterns and Genetic Insights Into a Rare Phosphorylase Kinase B (PHKB)-Associated Case.
Venkata Renuka I, Ramamoorthy S, B V, et al.
Cureus 2024; (16(7)):e65474 doi:10.7759/cureus.65474.
PMID: 39188489
8
Novel mutations in the PHKB gene in an iranian girl with severe liver involvement and glycogen storage disease type IX: a case report and review of literature.
Beyzaei Z, Ezgu F, Geramizadeh B, et al.
BMC pediatrics 2021; (21(1)):175 doi:10.1186/s12887-021-02648-6.
PMID: 33858366
9
Molecular diagnosis of glycogen storage disease type IX using a glycogen storage disease gene panel.
Kim TH, Kim KY, Kim MJ, et al.
European journal of medical genetics 2020; (63(6)):103921 doi:10.1016/j.ejmg.2020.103921.
PMID: 32244026
10
A female patient with GSD IXc developing multiple and recurrent hepatocellular carcinoma: a case report and literature review.
Kido J, Mitsubuchi H, Watanabe T, et al.
Human genome variation 2021; (8(1)):45 doi:10.1038/s41439-021-00172-8.
PMID: 34876562
11
Expanding the clinicopathological-genetic spectrum of glycogen storage disease type IXd by a Chinese neuromuscular center.
Huang K, Duan HQ, Li QX, et al.
Frontiers in neurology 2022; (13()):945280 doi:10.3389/fneur.2022.945280.
PMID: 36034300
12
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Bisciglia M, Froissart R, Bedat-Millet AL, et al.
Journal of the neurological sciences 2021; (424()):117391 doi:10.1016/j.jns.2021.117391.
PMID: 33799212
13
Case Report: Perioperative Management of a Patient with Glycogen Storage Disease Type IXd.
Kawata K, Otsu H, Hu Q, et al.
Surgical case reports 2025; (11(1)) doi:10.70352/scrj.cr.25-0239.
PMID: 40923014
14
Glycogen storage disorder types IX: the mutation spectrum and ethnic distribution.
Geramizadeh B, Ezgu F, Beyzaei Z
Orphanet journal of rare diseases 2024; (19(1)):475 doi:10.1186/s13023-024-03488-0.
PMID: 39707443
15
Glycogen storage disease type IX: Long-term follow-up of 52 patients from three European countries.
Magner M, Šáhó R, Slavíková P, et al.
Molecular genetics and metabolism reports 2026; (46()):101297 doi:10.1016/j.ymgmr.2026.101297.
PMID: 41732189
16
Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency.
Bali DS, Goldstein JL, Fredrickson K, et al.
JIMD reports 2017; (37()):63-72 doi:10.1007/8904_2017_8.
PMID: 28283841
17
Expected or unexpected clinical findings in liver glycogen storage disease type IX: distinct clinical and molecular variability.
İnci A, Kılıç Yıldırım G, Cengiz Ergin FB, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(4)):451-462 doi:10.1515/jpem-2021-0278.
PMID: 35038814
18
Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis.
Weinstein DA, Steuerwald U, De Souza CFM, Derks TGJ
Pediatric clinics of North America 2018; (65(2)):247-265 doi:10.1016/j.pcl.2017.11.005.
PMID: 29502912

This page provides educational information about GSD IX genetics and subtypes. It does not replace professional medical advice. Always consult your child's geneticist or hepatologist regarding their specific diagnosis, monitoring, and care plan.

Get notified when new evidence is published on Glycogen storage disease due to liver phosphorylase kinase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents